Leveraging of CDISC Standards to Support Dissemination, Integration and Analysis of Raw Clinical Trials Data to Advance Open Science
|
|
- Ashley Hunt
- 6 years ago
- Views:
Transcription
1 Leveraging of CDISC Standards to Support Dissemination, Integration and Analysis of Raw Clinical Trials Data to Advance Open Science Ravi Shankar Research Scientist, Division of Systems Medicine, Stanford University Member, NIAID ImmPort 1
2 Open access to clinical trials data advances open science Broad open access to entire clinical trial data is on the rise Tremendous opportunity to evaluate new hypotheses that were not originally formulated in the studies by performing cross analysis of clinical trials by combining with other open biomedical datasets We are developing standards-based methodologies for uniformly representing clinical trial data to support dissemination, integration and analysis.
3 Industry and Government Opening the Clinical Trial Data Vault
4 immport.niaid.nih.gov
5 ImmPort redistributes data from major NIAID-funded programs Data from 60+ trials already released, involving: Collaborative Network for Clinical Research on Immune Tolerance Network Atopic Dermatitis Research Network (ADRN) Clinical Trials in Organ Transplantation (CTOT) Clinical Trials in Organ Transplantation in Children (CTOT-C) Population Genetics Analysis Program Protective Immunity for Special Populations HLA Region Genomics in Immune-mediated Diseases Maintenance of Macaque Specific Pathogen-Free Breeding Colonies Modeling Immunity for Biodefense Reagent Development for Toll-like and other Innate Immune Receptors Adjuvant Development Program Innate Immune Receptors and Adjuvant Discovery Program Human Immunology Project Consortium Non-human Primate Transplantation Tolerance Cooperative Study Group
6 Open Biomedical Datasets 5,178 compounds 1,300 off-patent FDA-approved drugs 700 bioactive tool compounds 2,000+ screening hits (MLPCN and others) 3,712 genes (shrna + cdna) targets/pathways of FDA-approved drugs (n=900) candidate disease genes (n=600) community nominations (n=500+) 15 cell types Banked primary cell types Cancer cell lines Primary htert immortalized Patient derived ips cells 5 community nominated
7 New Open Science by Integrating Open Clinical Trial Data with Biomedical Datasets Looking at data is good; reanalyzing it is great Clinical trial results can be reproduced and expanded Discover new markers for personalized medicine While individual studies are great, pooling studies may be more powerful Pooling experimental results enables new questions Let s learn why trials work and fail Linking open biomedical and clinical trial data will enable even more virtual studies and findings
8 Clinical Trial Data To support the integration and analysis of clinical trials data We are creating uniform representations of clinical trial data. We are enabling easy access to uniformly represented clinical trial data in analytical environments. represent Uniformly Represented Clinical Trial Data export bridge Open Clinical Trial Repositories Dissemination Analytical Environments (R, SAS) Analysis
9 The 5 Major Steps from Raw Data to to Publish to Ready-for-analysis 1. Scope the clinical trial data types that we want to include for dissemination purposes. 2. Define a set of clinical trial domain entities (an ontology) required to uniformly represent the clinical trial data. 3. Using the ontology, encode specific clinical trial data to create uniformly represented data. 4. Publish the encoded clinical trial data. 5. Create bridges between the encoded data and analytical environments to provide easy access to data for analysis.
10 Towards Minimum Information About Clinical Trial for Dissemination Study Summary Study Objectives and Outcome Measures Study Design Schedule of Activities Study Subjects Clinical Data Experimental Data Adverse Events Analysis Data
11 Building a Standards-Based Clinical Trial Ontology a Formal Description of the Clinical Trial Domain Leverage of data elements defined in CDISC Standards e.g. Study, Arm, Study Subject Link with appropriate reference biomedical ontologies Clinical Trial Ontology (CTO) PRM TDM CDASH SDTM Data Dissemination Elements ODM ADaM SEND BRIDG NCI Thesaurus SNOMED CT Use Upper-level, Structural and Domain Ontologies BFO RDF Data Cube GO NDF-RT BAO PRO CL IAO OGMS 11
12 Using Semantic web standards to represent and disseminate clinical trial data Semantic web standards allow data to be shared and reused over the web OWL Web Ontology Language SPARQL RDF Query Language RDF Resource Description Framework URI Uniform Resource Identifier
13 Describing the Clinical Trial Domain as a Set of OWL Axioms Descriptions of a clinical trial entity such as its parent entity, its relationships with other entities and value restrictions are formally expressed as logical axioms to create the Clinical Trial Ontology InterventionalStudy is a subtype of Study Study has title that is of type string arm relates Arm to a Study Study Subject is a subtype of Person with role as Subject Role
14 Exploring RDF Data Cube for representing and analyzing multi-dimensional longitudinal data CUBE - a set of observations indexed by dimensions (e.g., arms, months after transplant ) describing measures (e.g., standard height) interpreted according to attributes (e.g., z-score) OBSERVATION measured values (with attributes) at dimensions SLICE optional grouping of observations by fixing dimensions
15 Exploring RDF Data Cube for representing and analyzing multi-dimensional longitudinal data CUBE - a set of observations indexed by dimensions (e.g., arms, months after transplant ) describing measures (e.g., standard height) interpreted according to attributes (e.g., z-score) OBSERVATION measured values (with attributes) at dimensions SLICE optional grouping of observations by fixing dimensions
16 Identifying Data Elements using URI Each clinical trial data element is assigned a unique identifier, a URI Study: CCTPT_SW01 URI - Planned Activity: Medical History URI - Study Subject: Subject 10 URI -
17 Representing Clinical Trial Data as a Collection of RDF Triples In RDF, data is represented as triples predicate Subject Object arm1 Using the entities in the CTO ontology (Study, title, arm, Planned Activity, etc.), the entire CCTPT_SW01 data can be represented as a collection of RDF triples CCTPT_SW01 type of type of Arm Study CCTPT_SW01 CCTPT_SW01 arm title arm1 A double-blind randomized trial of steroid withdrawal label... arm1 Steroid withdrawal arm
18 Linked Clinical Trial Data The collection of RDF triples can be viewed as linked data And, can be linked to external data sets Study type of arm title CCTPT_SW01 A double-blind randomized trial of steroid withdrawal type of Arm arm1 label Steroid withdrawal arm NCI Thesaurus
19 Biomedical Research Data Moving Towards RDF
20 Open Clinical Trial Data can be part of the Open Linked Data Cloud CCTPT-SW01 Clinical Trial Data in RDF
21 RDF Encoding of Clinical Trials Data using a Standards-based Clinical Trial Ontology Clinical Trial Data Clinical Trial Ontology (OWL) represent OWL / RDF Editor Encoded Clinical Trials (RDF) CDISC Standards, Other Ontologies & Linked Data export bridge Open Clinical Trial Repositories Dissemination Analytical Environments (R, SAS) Analysis
22 Accessing RDF Encoded Clinical Trials Data as R Data Objects a protoype Clinical Trial Data Clinical Trial Ontology (OWL) represent OWL / RDF Editor Encoded Clinical Trials (RDF) CDISC Standards, Other Ontologies & Linked Data export Jena RDF API bridge rrdf Open Clinical Trial Repositories Dissemination Clinical Trial Data Objects in R Analysis
23 Loading the RDF Encoded Clinical Trial Data in R a prototype bridge Create R data classes that correspond to the Clinical Trial Ontology (CTO) entities. CTO Entities Study title (string) R Classes Study <- setrefclass("study", fields = list(title = "character )) Query the RDF triples and populate the R classes with clinical trial data. Using R RDF libraries for SPARQL queries
24 > cctpt_sw01 = loadstudy(<clinical Trial URI>) A single line of R code can load the entire clinical trial data into R for analysis > cctpt_sw01 = loadstudy(" > cctpt_sw01$title title "A DOUBLE-BLIND RANDOMIZED TRIAL OF STEROID WITHDRAWAL IN SIROLIMUS- AND CYCLOSPORINE-TREATED PRIMARY TRANSPLANT RECIPIENTS" > cctpt_sw01$arms [[1]] Reference class object of class "Arm" Field "name": name "Control arm" [[2]] Reference class object of class "Arm" Field "name": name "Steroid withdrawal arm"
25 Summary We are using semantic web standards to create the clinical trial ontology (CTO) and to uniformly represent and disseminate clinical trial data. Our work in scoping the clinical trial ontology space can be a step towards a standard for minimum information about a clinical trial. We are developing bridges between encoded clinical trial data and analytical environments to enable easy access to clinical trial data. We are enabling pooling of clinical trials data and integration with other biomedical datasets to advance open science. 25
26 Acknowledgements NIAID ImmPort at Northrop Grumman (Jeff Wiser and team) Stanford University (Atul Butte and team) University of Buffalo (Barry Smith and team) Funding: NIAID Bioinformatics Integration Support Contract (BISC) HSN C Initiating discussions with the CDISC community 26
CDISC/TransCelerate Collaboration and TransCelerate work streams. -Clinical Data Standards -Common Protocol Template -esource
CDISC/TransCelerate Collaboration and TransCelerate work streams -Clinical Data Standards -Common Protocol Template -esource July 2016 TransCelerate Clinical Data Standards Project Opportunity
More informationIndustrialized Clinical Data Standards Management Speed of automation, Power of accuracy and Transforming clinical data into business intelligence
Industrialized Clinical Standards Management Speed of automation, Power of accuracy and Transforming clinical data into business intelligence Executive Summary The majority of commercially available legacy
More informationJanus Clinical Trials Repository: Modernizing the Review Process through Innovation
Janus Clinical Trials Repository: Modernizing the Review Process through Innovation Lilliam Rosario, Ph.D. Director Office of Computational Science Food and Drug Administration Janus Clinical Trials Repository
More informationSteps and Slides of Implementing Global Standards Producing High Quality Programming Outputs Edition
Steps and Slides of Implementing Global Standards Producing High Quality Programming Outputs Edition David Izard, MS Terek Peterson, MBA Richard Addy, MS CDISC ODM SDTM LAB CDASH ADaM PRM SEND Controlled
More informationCDISC Controlled Terminology across the Clinical Trial Continuum. Bay Area Implementation Network 6 March 2008
CDISC Controlled Terminology across the Clinical Trial Continuum Bay Area Implementation Network 6 March 2008 Bron Kisler Co-Founder / Director of Terminology CDISC Terminology Initiative Overview / Background
More informationOctober, Integration and Implementation of CDISC Standards
Integration and Implementation of CDISC Standards October, 2008 Barbara Lentz, Associate Director, Electronic Data Management Standards, Processes & Training Pat Majcher, Statistical Reporting Services
More informationCDISC Tech Webinar Leveraging CDISC Standards to Drive Crosstrial Analytics; Graph Technology and A3 Informatics 26 OCT 2017
CDISC Tech Webinar Leveraging CDISC Standards to Drive Crosstrial Analytics; Graph Technology and A3 Informatics 26 OCT 2017 CDISC 2017 1 Panelists Jim LaPointe Managing Director, Cambridge Semantics Patrick
More informationFrom Standards that Cost to Standards that Save: Cost Effective Standards Implementation
From Standards that Cost to Standards that Save: Cost Effective Standards Implementation Jeffrey M. Abolafia, Rho, Chapel Hill, NC Frank DiIorio, CodeCrafters Inc., Philadelphia, PA Warning This presentation
More informationCDISC Standards: Current and Future
CDISC 2010 CDISC Standards: Current and Future CDISC Japan Interchange Tokyo, Japan 20 July 2010 Rebecca D. Kush, PhD President and CEO, CDISC Clinical Research Standards (Content) (Protocol-driven Research;
More informationCDISC UK Network face to face Reading
CDISC UK Network face to face Reading Paul Houston, CDISC Head of European Operations CDISC Update and European Activity 2 CDISC Values and Principals Core value Foster CDISC community is altruistic
More informationCDASH Clinical Data Acquisition Standards Harmonization
CDISC Italian User Group Meeting 16 November 2007 CDASH Clinical Data Acquisition Standards Harmonization 1 Outline Background Organization Goals Timelinesand Process Review of progress Results Future
More informationDisease Compass A Navigation System for Disease Knowledge based on Ontology and Linked Data Techniques
Disease Compass A Navigation System for Disease Knowledge based on Ontology and Linked Data Techniques Kouji Kozaki,*, Yuki Yamagata, Riichiro Mizoguchi,*, Takeshi Imai and Kazuhiko Ohe ISIR, Osaka University,
More informationEnd-to-End Management of Clinical Trials Data
End-to-End Management of Clinical Trials Data A Revolutionary Step Toward Supporting Clinical Trials Analysis Over the Next Decades of Clinical Research WHITE PAPER SAS White Paper Table of Contents Introduction....
More informationWhat is Genetic Engineering?
Selective Breeding Selective Breeding is when someone (humans) breed organisms with specific traits in order to produce offspring having those same traits. This is also called artificial selection, the
More informationQIAN ZHU. Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA CUI TAO
EXPLORING THE PHARMACOGENOMICS KNOWLEDGE BASE (PHARMGKB) FOR REPOSITIONING BREAST CANCER DRUGS BY LEVERAGING WEB ONTOLOGY LANGUAGE (OWL) AND CHEMINFORMATICS APPROACHES * QIAN ZHU Department of Health Sciences
More informationPharmaSUG Paper PO12
PharmaSUG 2016 - Paper PO12 CDISC Standards End-to-End: Transitional Hurdles Alyssa Wittle, Chiltern International, King of Prussia, PA Christine McNichol, Chiltern International, King of Prussia, PA Antonio
More information20.453J / 2.771J / HST.958J Biomedical Information Technology
MIT OpenCourseWare http://ocw.mit.edu 20.453J / 2.771J / HST.958J Biomedical Fall 2008 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms. 2.771J 20.453J
More informationBiomarker Data Management in Clinical Trials: Addressing the Challenges of the New Regulatory Landscape
Biomarker Data Management in Clinical Trials: Addressing the Challenges of the New Regulatory Landscape Introduction Biomarkers and specialty labs are core to modern clinical trials.the broad and evergrowing
More informationUsing semantic web technology to accelerate plant breeding.
Using semantic web technology to accelerate plant breeding. Pierre-Yves Chibon 1,2,3, Benoît Carrères 1, Heleena de Weerd 1, Richard G. F. Visser 1,2,3, and Richard Finkers 1,3 1 Wageningen UR Plant Breeding,
More informationExploration des données d essais cliniques en utilisant le standard CDISC
Exploration des données d essais cliniques en utilisant le standard CDISC Florence Kussener French System Engineer Florence.Kussener@jmp.com SAS Institute AGENDA Outcomes of using CDISC standards Case
More informationMachine Learning in Pharmaceutical Research
Machine Learning in Pharmaceutical Research Dr James Weatherall Global Director of Biomedical & Clinical Informatics AstraZeneca Research & Development October 2011 Overview Background: Pharmaceutical
More informationThe use of electronic Health Records in Clinical Research - The value of CDISC Standards
The use of electronic Health Records in Clinical Research - The value of CDISC Standards FH-Prof. Dr. Jozef Aerts University of Applied Sciences FH Joanneum Graz, Austria Who is Jozef Aerts? CDISC volunteer
More informationFood and Drug Administration (FDA) 101
Food and Drug Administration (FDA) 101 What is the Food and Drug Administration (FDA)? The FDA is an agency within the U.S. Department of Health and Human Services that is responsible for protecting the
More informationPutting CDISC Standards to Work How Converting to CDISC Standards Early in the Clinical Trial Process Will Make Your CDISC Investment Pay
How Converting to CDISC Standards Early in the Clinical Trial Process Will Make Your CDISC Investment Pay Jon Roth, Vice President, Data Sciences & Biometrics Authorized Trainer for ADaM, CDISC Mark Vieder,
More informationPCORI Methodology Standards: Academic Curriculum Patient-Centered Outcomes Research Institute. All Rights Reserved.
PCORI Methodology Standards: Academic Curriculum 2016 Patient-Centered Outcomes Research Institute. All Rights Reserved. Module 5: Architecture for Data Networks Category 7: Data Networks as Research-Facilitating
More informationTerminology Needs in Clinical Decision Support. Samson Tu Senior Research Scientist Center for Biomedical Informatics Research Stanford University
Terminology Needs in Clinical Decision Support Samson Tu Senior Research Scientist Center for Biomedical Informatics Research Stanford University 11th International Protégé Conference Workshop Amsterdam,
More informationInterlinked data and models using a semantic approach: example of the RECORD platform in the context of the ANAEE-France project
Interlinked data and models using a semantic approach: example of the RECORD platform in the context of the ANAEE-France project H.Raynal (U.MiAT, INRA, Toulouse), A.Chanzy (UMR EMMAH, INRA, Avignon),
More informationClinical Information Interoperability Council (CIIC) Providing a Shared Repository of Detailed Clinical Models for all of Health and Healthcare
Clinical Information Interoperability Council (CIIC) Providing a Shared Repository of Detailed Clinical Models for all of Health and Healthcare NIH HCS Collaboratory and PCORnet December 1, 2017 Stanley
More informationHD Regulatory Science Consortium (HD-RSC) A consortium aimed at accelerating treatments for Huntington s disease
HD Regulatory Science Consortium (HD-RSC) A consortium aimed at accelerating treatments for Huntington s disease Critical Path Institute / CHDI Foundation Huntington s Disease Regulatory Science Consortium
More informationThe 150+ Tomato Genome (re-)sequence Project; Lessons Learned and Potential
The 150+ Tomato Genome (re-)sequence Project; Lessons Learned and Potential Applications Richard Finkers Researcher Plant Breeding, Wageningen UR Plant Breeding, P.O. Box 16, 6700 AA, Wageningen, The Netherlands,
More informationProject Data Sphere Data Sharing in Cancer Research. Joel Beetsch, PhD Faster Cures, November 4th, 2013
Project Data Sphere Data Sharing in Cancer Research Joel Beetsch, PhD Faster Cures, November 4th, 2013 Disclaimer The opinions expressed in this presentation are my own, and not that of either Celgene
More informationDrug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research
Drug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research Drug Development Process by which new chemical entities
More informationImplementation and Operation of CDISC ODM-based EDC by UMIN
Implementation and Operation of CDISC ODM-based EDC by UMIN Takahiro Kiuchi, M.D., Ph.D. UMIN Center, The University of Tokyo Hospital, Tokyo, Japan 1 Content 1. CDISC standards and academic research 2.
More informationJMP JMP Pro JMP Genomics JMP Clinical JMP Add-Ins
JMP FAMILY OF PRODUCTS: SOFTWARE FOR LIFE SCIENTISTS JMP JMP Pro JMP Genomics JMP Clinical JMP Add-Ins CLINICAL TRIAL DATA REVIEWS Randomized clinical trial remains the gold standard for evaluating efficacy
More informationSNOMED CT in the Age of Precision Medicine
SNOMED CT in the Age of Precision Medicine Charles Gutteridge, Clinical Engagement Lead EMEA, SNOMED International @ gutteridgec HOW DO HUMANS ACT? 31414400 16064300 230063004 Dr Charles Gutteridge Clinical
More informationTOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS
TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER
More informationEvolving Regulatory Guidance on Submission of Standardized Data. James R. Johnson, PhD RTP CDISC User Network
Evolving Regulatory Guidance on Submission of Standardized Data James R. Johnson, PhD RTP CDISC User Network 2014-06-11 Originally Presented at PhUSE Conference 2013 Brussels, Belgium (Paper Number: RG03)
More informationMaking the most of existing evidence in the OHDSI evidence generation environment
Making the most of existing evidence in the OHDSI evidence generation environment An update from the Knowledge Base (Laertes) workgroup Richard D Boyce, Martijn Schuemie, Anthony Sena April 12 th, 2016
More informationLOINC in Regulated Clinical Research a Lab LOINC Steeringg Committee Meeting 08 June 2017
LOINC in Regulated Clinical Research a Lab LOINC Steeringg Committee Meeting 08 June 2017 Lauren Becnel, Ph.D. VP, Biomedical Informatics & Alliances, CDISC Asst Prof, Duncan Comprehensive Cancer Center,
More informationApplication of Deep Learning to Drug Discovery
Application of Deep Learning to Drug Discovery Hase T, Tsuji S, Shimokawa K, Tanaka H Tohoku Medical Megabank Organization, Tohoku University Current Situation of Drug Discovery Rapid increase of R&D expenditure
More informationInteroperability for clinical research Observational Health Data Sciences and Informatics (OHDSI)
9 ème École d'eté Méditerranéenne d'information en Santé Corte, France July 18, 2017 Interoperability for clinical research Observational Health Data Sciences and Informatics (OHDSI) Olivier Bodenreider
More informationBig Data & Clinical Informatics
Big Data & Clinical Informatics Client Overview A leading clinical intelligence company that powers healthcare providers, life sciences and research organizations to make better-informed, more confident
More informationThe INFRAFRONTIER Research Infrastructure Michael Hagn Helmholtz Zentrum München
The INFRAFRONTIER Research Infrastructure Michael Hagn Helmholtz Zentrum München High-quality resources and services for biomedical research European Research Infrastructure for the generation, systemic
More informationTHE GETTY VOCABULARIES TECHNICAL SOLUTIONS OVERVIEW
AAT TGN ULAN CONA THE GETTY VOCABULARIES TECHNICAL SOLUTIONS OVERVIEW International Working Group Meetings Friday, September 5, 2014 Joan Cobb IT Specialists Project Manager Getty Information Technology
More informationSemantic Enrichment and the Information Manager
WHITEPAPER Semantic Enrichment and the Information Manager Turning Content into Insight It is more resource intensive to bring a drug to market than ever before: Pharmaceutical companies spend an average
More informationRare Diseases: Challenges and Opportunities NIH Perspective
Rare Diseases: Challenges and Opportunities NIH Perspective Stephen C. Groft, Pharm.D. Office of Rare Diseases Research (ORDR) National Center for Advancing Translational Science (NCATS) National Institutes
More informationApplication of Deep Learning to Drug Discovery
Application of Deep Learning to Drug Discovery Hiroshi Tanaka Tohoku Medical Megabank Orga nization, Tohoku University Current Situation of Drug Discovery Rapid increase of R&D expenditure More than 1B
More informationCDISC Production Standards Status & Plans
Bay Area User Network CDISC Production Standards Status & Plans Wayne R. Kubick Sr. Vice President, Lincoln Technologies CDISC Technical Director SDS Team Leader Agenda Topics The role and work of the
More informationONTOLOGY BASED INFORMATION EXTRACTION FOR DISEASE INTELLIGENCE
International Journal of Research in Computer Science eissn 2249-8265 Volume 2 Issue 6 (2012) pp. 7-19, A Unit of White Globe Publications doi: 10.7815/ijorcs.26.2012.051 ONTOLOGY BASED INFORMATION EXTRACTION
More informationACCELERATING GENOMIC ANALYSIS ON THE CLOUD. Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes
ACCELERATING GENOMIC ANALYSIS ON THE CLOUD Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia
More informationEnhancing Laboratory Data Infrastructure to Access Real-World Evidence (RWE) for in vitro Diagnostics (IVDs): Three Models for RWE Use
Enhancing Laboratory Data Infrastructure to Access Real-World Evidence (RWE) for in vitro Diagnostics (IVDs): Three Models for RWE Use Michael Waters, Ph.D. Michael.Waters@fda.hhs.gov Office of In Vitro
More informationForthcoming Calls for Proposals (10/11) Barcelona 28 June 2013
Forthcoming Calls for Proposals (10/11) Barcelona 28 June 2013 Indicative list Proposed topic /11 /11 /11 Identification and validation of innovative clinical endpoints for Osteoarthritis European genotype-phenotype
More informationSemantic Technology for Information Management. Gilbane Conference
Semantic Technology for Information Management Gilbane Conference November 29, 2007 Discussion Agenda Case Study - A Global Pharma s R&D Information Challenge Enterprise Semantic Architecture and Strategies
More informationDeployment of SAS Programming Contract Staff: Pathway to Sinkhole or Best Strategy for Programming Division? Parag Shiralkar, Eliassen Group, NJ, USA
PharmaSUG 2013 Paper MS04 Deployment of SAS Programming Contract Staff: Pathway to Sinkhole or Best Strategy for Programming Division? Parag Shiralkar, Eliassen Group, NJ, USA Abstract In pharmaceutical
More informationApplying SDTM and ADaM to the Construction of Datamarts in Support of Cross-indication Regulatory Requests
Applying SDTM and ADaM to the Construction of Datamarts in Support of Cross-indication Regulatory Requests Data-what? This presentation will discuss some of the complexities involved when integrating study
More informationJohn Gurdon was testing the hypothesis of genomic equivalence or that when cells divide they retain a full genomic compliment.
1. (15 pts) John Gurdon won the 2012 Nobel Prize in Physiology or Medicine for work he did in the 1960 s. What was the major developmental hypothesis he set out to test? What techniques did he development
More informationAEO: a realism-based biomedical ontology for the representation of adverse events
AEO: a realism-based biomedical ontology for the representation of adverse events Yongqun He 1, Zuoshuang Xiang 1, Sirarat Sarntivijai 1, Luca Toldo 2, Werner Ceusters 3 1 University of Michigan Medical
More informationFDA Perspective on the Preclinical Development of Cancer Vaccines
FDA Perspective on the Preclinical Development of Cancer Vaccines Richard D. McFarland Ph.D., M.D. Medical Officer CBER/OCTGT/DCEPT mcfarlandr@cber.fda.gov Cancer Vaccine Clinical Trials Workshop Alexandria,
More informationManagement in Pharmaceutical Industry
Master Program Management: Industrial Management Module: Chemistry for Drug Substances Management in Pharmaceutical Industry Prof. Tatsiana Savitskaya Assoc. Prof. Iryna Kimlenka Lectures 5,6 The Key Aspects:
More informationIntroduction to Bioinformatics
Introduction to Bioinformatics Richard Corbett Canada s Michael Smith Genome Sciences Centre Vancouver, British Columbia June 28, 2017 Our mandate is to advance knowledge about cancer and other diseases
More informationIntroducing a Highly Integrated Approach to Translational Research: Biomarker Data Management, Data Integration, and Collaboration
Introducing a Highly Integrated Approach to Translational Research: Biomarker Data Management, Data Integration, and Collaboration 1 2 Translational Informatics Overview Precision s suite of services is
More informationChapter 1. Pharmaceutical Industry Overview
Chapter 1 Pharmaceutical Industry Overview 1.1 Introduction 2 1.2 Regulations 2 1.2.1 Health Insurance Portability and Accountability Act 2 1.2.2 The Code of Federal Regulations 3 1.2.3 Guidance for Industry
More informationSEMANTIC DATA PLATFORM FOR HEALTHCARE. Dr. Philipp Daumke
SEMANTIC DATA PLATFORM FOR HEALTHCARE Dr. Philipp Daumke ABOUT AVERBIS Founded: 2007 Location: Team: Focus: Current Sectors: Freiburg, Germany Domain & IT-Experts Leverage structured & unstructured information
More informationTargeted Drug Discovery through Data Mining. Copyright 2000 SAS EMEA
Targeted Drug Discovery through Data Mining John Brocklebank, PhD Development Director for Enterprise Miner Wayne Thompson, PhD Product Strategist Data Mining Introduction! This presentation will provide
More informationThe Innovative Medicines Initiative Socio-economic impacts
The Innovative Medicines Initiative Socio-economic impacts Pierre Meulien, IMI Executive Director European Innovation Summit European Parliament 08.12.2015 Closed & open innovation Filing Approval HTA
More informationEngineering Genetic Circuits
Engineering Genetic Circuits I use the book and slides of Chris J. Myers Lecture 0: Preface Chris J. Myers (Lecture 0: Preface) Engineering Genetic Circuits 1 / 19 Samuel Florman Engineering is the art
More informationNCI Research Networks Model for Collaboration with Bioelectronics Round Table
NCI Research Networks Model for Collaboration with Bioelectronics Round Table Larry Clarke, Cancer Imaging Program DCDT, NCI Detail: NIBIB Guest Scientist: NIST 1 Bioelectronics Round Table Research Triangle
More informationNew Frontiers in Personalized Medicine
New Frontiers in Personalized Medicine Oracle Open World Shanghai 2013 Neil de Crescenzo SVP and GM 1 Safe Harbor Statement The following is intended to outline our general product direction. It is intended
More informationSMEs in IMI2 Calls for Proposals
SMEs in IMI2 Calls for Proposals Why should an SME participate in an IMI project IMI projects are focused on translating excellent research into real world outcomes an opportunity for SMEs Unique collaborative
More informationCDISC Data Standards Validation
CDISC Data Standards Validation How can it be done? Peter Van Reusel Business Unit Director Business & Decision Life Sciences Tel +32 2 774 11 00 Fax +32 2 774 11 99 Mobile +32 476 54 59 17 peter.vanreusel@businessdecision.com
More informationTranslational Medicine From Discovery to Health
Translational Medicine From Discovery to Health Jamal A. Ibdah, MD, PhD Sr. Associate Dean & Director, MU Institute for Clinical and Translational Science Translational Medicine Translational Medicine
More informationRegulatory Challenges of Global Drug Development in Oncology. Jurij Petrin, M.D. Princeton, NJ
Regulatory Challenges of Global Drug Development in Oncology Jurij Petrin, M.D. Princeton, NJ Topics General global R&D issues Regulatory issues with global oncology drug development US FDA initiatives
More informationQuestion and Answer Guide Regarding Notification on Practical Operations of Electronic Study Data Submissions
Administrative Notice April 27, 2015 To: Prefectrual Health Department (Bureau) Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Question
More informationFuture of the Project. BioMedBridges 3rd Annual General Meeting 18 February 2015, Munich Janet Thornton
Future of the Project BioMedBridges 3rd Annual General Meeting 18 February 2015, Munich Janet Thornton What were goals of BioMedBridges? GOAL 1: To provide computational data and service bridges between
More informationMaximizing opportunities towards achieving clinical success D R U G D I S C O V E R Y. Report Price Publication date
F o r a c l e a r e r m a r k e t p e r s p e c t i v e Early Stage Drug Safety Strategies & Risk Management Maximizing opportunities towards achieving clinical success D R U G D I S C O V E R Y Report
More informationPersonalized Medicine
Personalized Medicine Dr. Pablo Mentzinis, Director Government Relations, SAP SE Courtesy by Dominik Bertram, Marc von der Linden, Péter Adorján, SAP June 2016 1. Traditional medicine vs. personalized
More informationGenomic Medicine in France
Genomic Medicine in France Catherine Nguyen, PhD Director ITMO GGB Genetic, Genomic & Bioinformatic Advancing Disease Modeling in Animal-Based research in Support of Precision Medecine: a Workshop ILAR
More informationThe HLA Community s Success in Combining Clinical & Genomic Data
The HLA Community s Success in Combining Clinical & Genomic Data Elizabeth Trachtenberg MS, PhD, DABHI Director, Center for Applied Genomics HLA/Immunogenetics Laboratory Children s Hospital & Research
More informationData & Materials Sharing Agreement. Collaboration for AIDS Vaccine Discovery. Clinical Trials Data Sharing Addendum & Related Information
Data & Materials Sharing Agreement Collaboration for AIDS Vaccine Discovery Clinical Trials Data Sharing Addendum & Related Information I. Overview of this Document The primary purpose of this document
More informationWebinar IMI2 Call 14 Opportunities for SMEs
Webinar IMI2 Call 14 Opportunities for SMEs 19 March 2018 Agenda How to use GoToWebinar Catherine Brett, IMI Opportunities for SMEs Colm Carroll, IMI Questions & answers How to use GoToWebinar - audio
More informationElectronic Healthcare Record and Clinical Research in Cardiovascular Radiology. HL7 CDA and CDISC ODM Interoperability
Electronic Healthcare Record and Clinical Research in Cardiovascular Radiology. HL7 CDA and CDISC ODM Interoperability A. El Fadly a, C. Daniel ab, C. Bousquet ab, T. Dart b, P-Y. Lastic c, P. Degoulet
More informationTranslational Research
Translational Research Paddy Johnston Chair, MRC Translational Research Overview Group October 2012 Translational Research Strategy and its delivery To accelerate patient benefit and increase economic
More informationE2ES to Accelerate Next-Generation Genome Analysis in Clinical Research
www.hcltech.com E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research whitepaper April 2015 TABLE OF CONTENTS Introduction 3 Challenges associated with NGS data analysis 3 HCL s NGS Solution
More informationA journey into European factories of the future: The best Horizon 2020 projects are visiting Graz
Karl Hribernik BIBA Bremer Institut für Produktion und Logistik GmbH Horizon 2020 European Union Funding for Research & Innovation Agenda 1. FALCON Project Details 2. Consortium 3. Objectives & Approach
More informationBiological resources in the Plant Biology and Breeding division of INRA
Plant Biology and Breeding Division Biological resources in the Plant Biology and Breeding division of INRA A-F Adam-Blondon Eurisco workshop, Angers, October 12th 2016 French National Institute for Research
More informationCDISC International Interchange Program Embracing a Changing Landscape Standards to Connect Research and Patient Care
CDISC International Interchange Program Embracing a Changing Landscape Standards to Connect Research and Patient Care B e t h e s d a N o r t h M a r r i o t t H o t e l a n d C o n f e r e n c e C e n
More informationOntologies examples and applications
Web Science & Technologies University of Koblenz Landau, Germany Ontologies examples and applications 2 UMLS - Unified Medical Language System Framework consisting of several knowledge bases and according
More informationComments on Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants
Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 The American Society of Human Genetics 9650 Rockville Pike Bethesda, MD 20814 24 December
More informationMICROARRAYS+SEQUENCING
MICROARRAYS+SEQUENCING The most efficient way to advance genomics research Down to a Science. www.affymetrix.com/downtoascience Affymetrix GeneChip Expression Technology Complementing your Next-Generation
More informationInnovations in Clinical
Innovations in Clinical Accelerating Insights & Data-Driven Decisions Masha Hoffey Director, Clinical Analytics 15 September 2016 HUMAN HEALTH ENVIRONMENTAL HEALTH 2014 PerkinElmer Contents Introduction
More informationIntegrating Pharmacogenomics into Decision Making
Integrating Pharmacogenomics into Decision Making Munir Pirmohamed David Weatherall Chair of Medicine and NHS Chair of Pharmacogenetics Department of Molecular and Clinical Pharmacology Institute of Translational
More informationOntology: A Vision for the Future and Its Realization. What Is An Ontology?
Ontology: A Vision for the Future and Its Realization Mark A. Musen (Stanford University) Barry Smith (University at Buffalo) What Is An Ontology? The study of being A discipline co-opted by computer science
More informationEileen Navarro MD, FACP Medical Officer, OCS, OTS, CDER, FDA
Eileen Navarro MD, FACP Medical Officer, OCS, OTS, CDER, FDA 1 www.fda.gov WHAT MEDICAL REVIEWERS CAN DO WITH STANDARDIZED DATA AND METADATA RECEIVED IN MODULE 5 Eileen Navarro, MD, FACP OCS/OTS/CDER/FDA
More informationData Types in Bioinformatics
Data Types in Bioinformatics Patient diagnostics Karyotypes Fluorescent In Situ Hybridization Polymorphisms Microarrays, from pictures to interpretation Genetic sequence, from raw trace files to base-calls
More informationCDASH 2.0. Berlin Éanna Kiely CDISC Engineer
CDASH 2.0 Berlin Éanna Kiely CDISC Engineer 2016-09-13 Agenda CDASH 1.1 & CDASHIG 2.0 CDASH Concepts TAUG Examples Current Regulatory Perspective on CDASH Questions 2 CDASH: CDISC End to End Clinical Data
More informationGene expression connectivity mapping and its application to Cat-App
Gene expression connectivity mapping and its application to Cat-App Shu-Dong Zhang Northern Ireland Centre for Stratified Medicine University of Ulster Outline TITLE OF THE PRESENTATION Gene expression
More informationIN the inaugural issue of the IEEE Transactions on Services Computing (TSC), I used SOA, service-oriented consulting
IEEE TRANSACTIONS ON SERVICES COMPUTING, VOL. 1, NO. 2, APRIL-JUNE 2008 62 EIC Editorial: Introduction to the Body of Knowledge Areas of Services Computing Liang-Jie (LJ) Zhang, Senior Member, IEEE IN
More informationDevelopment Stage of Therapeutic Vaccines: The Regulator s View
Development Stage of Therapeutic Vaccines: The Regulator s View Thomas Hinz Head, Section Therapeutic Vaccines Paul Ehrlich Institute, Germany thomas.hinz@pei.de 1 DISCLAIMER This is the personal views
More informationDana-Farber Cancer Institute Speeds Medical Research with Advanced Data Warehouse
Dana-Farber Cancer Institute Speeds Medical Research with Advanced Data Warehouse Dana-Farber Cancer Institute Boston, MA www.dana-farber.org Industry: Healthcare Annual Revenue: US$665.7 million Employees:
More information